Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese society of hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42:1235–481.
Fujiyoshi A, Ohkubo T, Miura K, Murakami Y, Nagasawa SY, Okamura T, et al. Blood pressure categories and long-term risk of cardiovascular disease according to age group in Japanese men and women. Hypertens Res. 2012;35:947–53.
Takashima N, Ohkubo T, Miura K, Okamura T, Murakami Y, Fujiyoshi A, et al. Long-term risk of BP values above normal for cardiovascular mortality: a 24-year observation of Japanese aged 30 to 92 years. J Hypertens. 2012;30:2299–306.
Article CAS PubMed Google Scholar
Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA. 2002;288:1882–8.
Takase H, Dohi Y, Toriyama T, Okado T, Tanaka S, Sato K, et al. Does B-type natriuretic peptide predict the new onset of hypertension? Hypertens Res. 2008;31:1737–44.
Article CAS PubMed Google Scholar
Takase H, Dohi Y, Toriyama T, Okado T, Tanaka S, Sonoda H, et al. Evaluation of risk for incident hypertension using glomerular filtration rate in the normotensive general population. J Hypertens. 2012;30:505–12.
Article CAS PubMed Google Scholar
Takase H, Sugiura T, Murai S, Yamashita S, Ohte N, Dohi Y. Use of electrocardiography to predict future development of hypertension in the general population. Medicine (Baltimore). 2016;95:e3483.
Takase H, Sugiura T, Murai S, Yamashita S, Ohte N, Dohi Y. Carotid intima-media thickness is a novel predictor of new onset of hypertension in normotensive subjects. Medicine (Baltimore). 2017;96:e7710.
Takase H, Sugiura T, Yamashita S, Kawakatsu N, Hayashi K, Kin F, et al. Significance of blood pressure variability in normotensive individuals as a risk factor of developing hypertension. Blood Press. 2024;33:2323967. (e-pub ahead of print 11 Mar 2024)
Schutte AE, Schutte R, Huisman HW, van Rooyen JM, Fourie CM, Malan NT, et al. Blood pressure variability is significantly associated with ECG left ventricular mass in normotensive Africans: the SABPA Study. Hypertens Res. 2011;34:1127–34.
Kawai T, Ohishi M, Kamide K, Onishi M, Takeya Y, Tatara Y, et al. The impact of visit-to-visit variability in blood pressure on renal function. Hypertens Res. 2012;35:239–43.
Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig. 2010;1:212–28.
Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K, et al. Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb. 2007;14:155–8.
Article CAS PubMed Google Scholar
Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.
Article CAS PubMed Google Scholar
Morin DP, Oikarinen L, Viitasalo M, Toivonen L, Nieminen MS, Kjeldsen SE, et al. QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study. Eur Heart J. 2009;30:2908–14.
Hummel SL, Skorcz S, Koelling TM. Prolonged electrocardiogram QRS duration independently predicts long-term mortality in patients hospitalized for heart failure with preserved systolic function. J Card Fail. 2009;15:553–60.
Article PubMed PubMed Central Google Scholar
Aro AL, Anttonen O, Tikkanen JT, Junttila MJ, Kerola T, Rissanen HA, et al. Intraventricular conduction delay in a standard 12-lead electrocardiogram as a predictor of mortality in the general population. Circ Arrhythm Electrophysiol. 2011;4:704–10.
Singleton MJ, German C, Hari KJ, Saylor G, Herrington DM, Soliman EZ, et al. QRS duration is associated with all-cause mortality in type 2 diabetes: The diabetes heart study. J Electrocardiol. 2020;58:150–4.
Domain G, Chouquet C, Réant P, Bongard V, Vedis T, Rollin A, et al. Relationships between left ventricular mass and QRS duration in diverse types of left ventricular hypertrophy. Eur Heart J Cardiovasc Imaging. 2022;23:560–8.
Oikarinen L, Nieminen MS, Viitasalo M, Toivonen L, Jern S, Dahlöf B, et al. QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension. 2004;43:1029–34.
Article CAS PubMed Google Scholar
Desai AP, Mohan P, Roubal AM, Bettencourt R, Loomba R. Geographic variability in liver disease-related mortality rates in the United States. Am J Med. 2018;131:728–34.
Comments (0)